EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2022.11.17
CanSinoBIO Leads Sino-Indonesian Collaboration on Mucosal Vaccine Development
2022.11.10
CanSino Biologics and AstraZeneca Sign Strategic Collaboration Agreement to Deepen Research on Rare Diseases
2022.11.10
CanSinoBIO’s Convidecia Air™ Approved for Emergency Use in Morocco
2022.10.25
CanSino Biologics Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai
2022.10.06
CanSinoBIO to Present Latest Data on Convidecia Air™ at the World Vaccine Congress Europe 2022
2022.09.04
CanSinoBIO's Convidecia Air™ Receives Approval in China
2022.08.18
Convidecia Air™ Receives Clinical Trial Approval in Malaysia
2022.05.20
COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
2022.04.25
CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research
2022.03.22
CanSinoBIO's Convidecia Approved as Heterologous Booster in Malaysia and Indonesia
1234568